Abstract:Angiogenesis, the formation of new blood vessels, is a complex and dynamic process regulated by various pro- and anti-angiogenic molecules, which plays a crucial role in tumor growth, invasion, and metastasis. With the advances in molecular and cellular biology, various biomolecules such as growth factors, chemokines, and adhesion factors involved in tumor angiogenesis has gradually been elucidated. Targeted therapeutic research based on these molecules has driven anti-angiogenic treatment to become a promising strategy in anti-tumor therapy. The most widely used anti-angiogenic agents include monoclonal antibodies and tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factor (VEGF) pathway. However, the clinical benefit of this modality has still been limited due to several defects such as adverse events, acquired drug resistance, tumor recurrence, and lack of validated biomarkers, which impel further research on mechanisms of tumor angiogenesis, the development of multiple drugs and the combination therapy to figure out how to improve the therapeutic efficacy. Here, we broadly summarize various signaling pathways in tumor angiogenesis and discuss the development and current challenges of anti-angiogenic therapy. We also propose several new promising approaches to improve anti-angiogenic efficacy and provide a perspective for the development and research of anti-angiogenic therapy.

Advances in Research on Mechanisms of Tumor Angiogenesis and Antiangiogenic Drugs

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Anti-cancer drugs targeting vascular endothelial growth factors and receptors:research advances

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

Anti-angiogenic therapy for colorectal cancer: on the way to getting better!

Advances in the Research of Tumor Angiogenesis Inhibitors

Advances in tumor vascular growth inhibition

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment

Mechanisms of angiogenesis in tumour

Anti-angiogenic Active Immunotherapy: a New Approach to Cancer Treatment

Research Development of Tumor Angiogenesis and Angiogenesis Inhibitors

[Mechanism Exploration and Future Prospects of Antiangiogenic Agents Improving Tumor Blood Supply and Oxygenation].

[Advances in the Research of Mechanisms of Promotion of Vascularization by Angiogenin and Its Application].

Research progress in tumor angiogenesis and drug resistance in breast cancer

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy

Progress in Anti-Angiogenesis Targeted Drugs

Angiogenic signaling pathways and anti-angiogenic therapy for cancer

Advances in Tumor Angiogenesis Inhibitor

Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization

The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment

Tumor angiogenesis and anti-angiogenic therapy